Objective: To detect immunoglobulin M (IgM) anti-Toxoplasma gondii antibodies and determine immunoglobulin G (IgG) titer and avidity in filter paper-embedded blood (FPEB) samples of pregnant women.
Introduction
Toxoplasma gondii can be transmitted vertically during pregnancy, causing congenital toxoplasmosis. 1 Only the tachyzoite, fast replicating stage present during the acute phase, is able to invade the placenta and the fetus. 2 In addition, this parasite stage is susceptible to chemotherapy, mainly based on anti-replication drugs, which are quite toxic for the host. Thus, diagnosis of the acute phase is of great importance in gravid women with positive serology before treatment is provided or invasive diagnostic procedures such as amniocentesis are performed. 3, 4 The presence of immunoglobulin M (IgM) antibodies (abs) is recognized as suggestive of acute infection. However, these abs may remain detectable for up to 12 years. 5, 6 Immunoglobulin G (IgG) abs are indicative of acute phase only if their titers are rising or are of low avidity. 7, 8 All these parameters are commonly evaluated using serum or plasma, but they require centrifugal separation from cloth, cold network if taken far from the laboratory, and special storage conditions, usually À20 1C.
Guthrie cards containing filter paper-embedded blood (FPEB) have been successfully used for diagnosis, including neonatal screening of T. gondii infection by means of IgM-or IgA-capture ELISA. 9, 10 They are easily transportable and relatively stable at a wide temperature range. Besides, FPEB sampling is less aggressive for patients when compared with any other syringe-based procedure. In this study, we evaluated the usefulness of FPEB to determine the presence of IgM and IgG abs, as well as to measure IgG avidity in pregnant women and in some newborns.
Methods
This study was reviewed and approved by the research and ethics committees of the National Institute of Pediatrics of the Ministry of Health of Mexico (registration no. 062/2003).
Patients and samples
All samples were selected by convenience from paired FPEB/serum banks of patients under screening protocols. To determine the usefulness of FPEB for IgM-capture testing, 100 samples from pregnant women earlier tested and confirmed positive for IgM (n ¼ 30) or negative to any antibody class (n ¼ 70) were selected. Random number tables were used to choose cases within subgroups.
A total of 11 pairs of serum and its corresponding FPEB had enough volume/filter paper to standardize IgG titration; from them nine samples could be tested for IgG avidity; three were taken from individuals suffering from acute infection; three were in the chronic phase and three were undetermined. Classification was based on serial samples, considering acute those with X4 Â increase of IgG abs, undetermined when the titer increased two times, and chronic if no increase was observed. Then, serum/FPEB pairs from 21 pregnant women and two newborns from ongoing pre-and neonatal screening projects were assessed for avidity.
IgM-capture ELISA A commercial IgM-capture FEIA (Labsystems, Vantaa, Finland) designed for newborn samples, was adapted for pregnant women but reassigning the cutoff by a receiver operating characteristic (ROC) curve.
IgG-ELISA and avidity tests A crude extract (CE) from pure tachyzoites of the RH strain was used for specific IgG detection as follows: high-binding plates (Maxisorp, Nunc Co., Rochester, NY, USA) were coated with 100 ml per well of T. gondii crude extract at 1.0 or 2.0 mg ml À1 in 0.1 M carbonate buffer pH 9.6, incubated overnight at 4 1C, and then washed three times with 200 ml per well of 0.1 M phosphate/0.15 M NaCl buffer, pH 7.2 added with 0.05% Tween 20 (PBS-T). After incubation with 1% bovine serum albumin in PBS-T for 30 min at 37 1C, washes were repeated. The serum samples were diluted 1:100, 1:200, 1:400 and 1:800 in PBS-T. One 3 mm circle of each FPEB sample (equivalent to 5 ml of blood) was cutoff and eluted overnight at 37 1C in 200 ml of the same buffer; then three twofold serial dilutions were performed and incubated at 37 1C for 2 h. The conditions for avidity testing included different treatments as follows: washing up five times with PBS-T alone, PBS-T added with 6 or 8 M urea, or incubation with 6 or 8 M urea during 30 min at 37 1C; these steps were followed by three washes with PBS-T. Development was done with a commercial peroxidase-anti human IgG conjugate diluted 1:1000 in PBS-T for 2 h at 37 1C and the substrate/chromogen solution (4 mg of orthophenylenediamine, 10 ml of 0.1 M citrate/citric acid and 4 ml of 30% H 2 O 2 ) until color development. The reaction was stopped with 50 ml per well of 1.0 N sulfuric acid, and the absorbance registered at 492 nm. For the calculation of the avidity coefficient, the absorbance of the wells treated with urea was divided by that of untreated wells.
11
Statistical analysis Diagnostic parameters were calculated using the standard formulae. 12 Significance of differences in avidity among toxoplasmosis-phase subgroups, sample dilutions and urea treatments were tested by the Kruskal-Wallis test, followed by the Mann-Whitney U-test for comparisons of two groups. Correlation between continuous numeric variables was measured by Pearson's linear regression. A P p0.05 was considered significant.
Results
In this study the detection of IgM and IgG abs, as well as the measurement of IgG avidity, were performed in FPEB samples from pregnant women. The use of a standard IgM-capture ELISA, usually employed for newborn's FPEB samples, presented high diagnostic parameters when the cutoff was re-calculated 4th  3rd  2nd  1st  4th  3rd  2nd   1st  4th  3rd  2nd 1st 4th 3rd 2nd Figure 1 Examples of IgG antibodies titration in serum and FPEB samples of four pregnant women. T. gondii antigen was used at 2 mg ml À1 .
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À1
): sensitivity, specificity and positive-negative predictive values were 91.7, 100, 82 and 95%, respectively.
Examples of paired serum/FPEB IgG titration curves are shown in Figure 1 ; whereas some cases presented virtually the same results in both samples (Figures 1a and b) , differences at certain dilutions were found in others (Figures 1c and d) .
Nevertheless, the detection of IgG abs in FPEBs strongly correlated with that in serum at the four dilutions tested, with highest values using the second and third (r ¼ 0.94 and r ¼ 0.92, respectively).
A significant difference in avidity between the acute and the undetermined/chronic phase was found using the CE at 2 mg ml À1 and treating the sampleFeither serum or FPEBFwith 6 M urea for 30 min, or washing with 8 M urea, without difference between the second and third sample dilutions (Figures 2 and 3) . The correlation between serum and FPEB was X0.89 for the second and third sample dilutions (Figure 4) . When 21 IgG-positive cases of unknown avidity were tested, a lower although significant correlation between serum and FPEB was observed ( Figure 5 ). As expected, no correlation between avidity values and levels of anti-T. gondii IgM abs in FPEB was found ( Figure 6 ). The avidity increase along time could also be detected in FPEB samples ( Figure 7 ).
Discussion
A long time between first screening and drug administration in women acutely infected by T. gondii might hinder treatment efficacy for prevention of vertical transmission or fetal damage. 13 This could particularly affect patients living in underprivileged areas, far from clinical facilities.
Screening of pregnant women is normally done by determination of IgG abs in serum (IgM in high prevalence areas), and acute phase diagnosed through IgG avidity or titer increase in serial samples within a 2 to 4 weeks interval. IgG and IgM abs have a low positive predictive value for acute phase diagnosis.
14 In addition, recent reports indicate that even IgG avidity is doubtful, since it can be low (that is, 'acute') for years. 15 Nevertheless, the presence of high-avidity IgG in the absence of IgM abs practically discards the possibility of acute phase, allowing the physician to focus on those cases with doubtful results, that is, detection of these markers in the first sample facilitates discrimination of chronically infected women.
In this work, we found that FPEB samples may be used to show anti-T. gondii IgM abs in pregnant women. In addition, titration of IgG abs and IgG avidity assessment was achieved. These determinations are normally performed using serum, but this sample must be taken with a syringe, separated from the cloth in a laboratory, and transported/stored at low temperatures, whereas FPEB is cheaper and easier to obtain, as well as stable in a wider range of temperatures. Thus, the results presented herein are important because FPEB samples might facilitate sampling and transport to the laboratory.
The IgM abs are currently searched in newborn FPEB samples. 9, 10 As far as we know, this has not been achieved in T. gondii diagnosis in filter paper blood I Cañ edo-Solares et al.
pregnant women; the technique applied to this sample was of high specificity and sensitivity (92 and 100%), once the cutoff was re-established. In areas of high prevalence this is relevant because IgM, instead of IgG screening must be performed, that is, the later would be positive in most cases. In addition, IgG abs could readily be titrated using FEPB samples, both from pregnant women and some newborns tested; thus, in case a second sample is required FPEB could be used to compare titers.
Even though actual avidity values were higher in FPEB than in serum, the correlation between the two samples supports the use of Guthrie cards to discriminate chronic infections. In few cases maturation of avidity could also be observed using FPEB samples, further sustaining its use for the assay. T. gondii diagnosis in filter paper blood I Cañ edo-Solares et al.
A limitation of this study is the small number of mother/ newborn pairs analyzed; data from more cases would have allowed determining the utility of FPEB for estimation of vertical transmission risk.
In conclusion, FPEB samples can be used for detection of specific IgM, titration of IgG abs and IgG avidity assessment, and thus are of value to diminish delay in clinical management of T. gondii-infected pregnant women. T. gondii diagnosis in filter paper blood I Cañ edo-Solares et al.
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